Epigenetic regulation refers to reversible chemical and structural changes to DNA and chromatin that alter gene activity without changing the DNA sequence. The main mechanisms include DNA methylation, histone modifications, chromatin remodeling, and non coding RNAs. Together they control when, where, and how strongly genes are expressed in different cell types and developmental stages.

DNA methylation usually occurs at cytosine bases in CpG dinucleotides and is generally linked to gene silencing, especially when present in gene promoters. Enzymes called DNA methyltransferases establish and maintain these patterns, while demethylation processes can reactivate genes. Histone modifications such as acetylation, methylation, phosphorylation, and ubiquitination occur on histone tails and influence how tightly DNA is wrapped around nucleosomes. Acetylation typically opens chromatin and promotes transcription, whereas specific methylation marks can either activate or repress genes, depending on the residue and number of methyl groups.

Chromatin remodeling complexes use ATP to reposition or restructure nucleosomes, making regulatory DNA elements more or less accessible to transcription factors. Non coding RNAs, including microRNAs and long non coding RNAs, guide protein complexes to particular genomic regions or transcripts, fine tuning gene expression post transcriptionally and at the chromatin level.

Epigenetic regulation plays central roles in cell differentiation, X chromosome inactivation, genomic imprinting, and environmental responses. Disruption of epigenetic patterns contributes to cancer, neurodevelopmental disorders, metabolic disease, and aging. Because epigenetic marks are dynamic and sometimes reversible, they are promising targets for therapies that aim to reset aberrant gene expression programs.